Case Studies in Improving HIV Prevention through Current and Emerging Strategies
|
Release Date: November 5, 2025 |
 |
Support for this activity has been made possible through educational grants from Gilead Sciences and Merck. |
- There are no fees to participate in the activity.
- Participants must view the activity description, including disclosures, and watch the video.
- At the conclusion of the program, go to: https://form.jotform.com/AcademyCME/W2TC25W
- Your certificate will be emailed to you within 24 hours
- If you have any questions, please contact [email protected] for assistance.
Resources
-
National HIV PrEP Curriculum Self Study: https://www.hivprep.uw.edu
-
National Clinician Consultation Center PrEP Online and Phone Consultation: 844-275-6222; https://nccc.ucsf.edu/clinician-consultation/prep-pre-exposure-prophylaxi
-
Centers for Disease Control & Prevention PrEP Guidelines (2021): https://stacks.cdc.gov/view/cdc/112360
-
CDC Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis (2025): https://www.cdc.gov/mmwr/volumes/74/wr/mm7435a1.htm
-
ACTHIV® Resources for the Care Team: https://acthiv.org/wp-content/uploads/2025/05/ACTHIV-Resources-for-HIV-Team-updated-03-21-25.pdf